Related Experiment Videos
Secretory IgA(S-IgA) levels in sera from patients with diffuse panbronchiolitis
1Third Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.
Japanese Journal of Medicine
|March 1, 1989
Summary
Serum secretory IgA (S-IgA) levels are significantly elevated in diffuse panbronchiolitis (DPB), indicating extensive airway infection. Higher S-IgA may help stage this chronic lung disease.
Area of Science:
- Immunology
- Pulmonology
- Medical Diagnostics
Background:
- Chronic airway diseases like diffuse panbronchiolitis (DPB), chronic bronchitis (CB), and bronchiectasis (BE) present distinct pathological states.
- Secretory immunoglobulin A (S-IgA) plays a role in mucosal immunity, and its serum levels may reflect airway inflammation and infection.
Purpose of the Study:
- To compare serum S-IgA levels in patients with DPB, CB, and BE.
- To investigate the relationship between serum S-IgA levels, bacterial infections (specifically Pseudomonas aeruginosa), and disease severity in these chronic bronchial conditions.
Main Methods:
- Serum S-IgA levels were measured in 33 patients with DPB, 13 with CB, and 24 with BE.
- Patients' sputum was analyzed for Pseudomonas aeruginosa infection.
- Serum S-IgA levels were correlated with clinical stage and presence of bacterial infection.
Main Results:
- Serum S-IgA levels were elevated in all three groups, significantly higher in DPB than CB, and intermediate in BE.
- Persistent bacterial infections, particularly P. aeruginosa, were common in DPB and BE patients.
- Highest S-IgA levels (>100 µg/ml) were observed in advanced DPB patients with P. aeruginosa-positive sputum.
Conclusions:
- Marked elevation of serum S-IgA in DPB is linked to extensive, chronic airway infections, especially in peripheral airways.
- Serum S-IgA serves as a valuable biomarker for assessing the clinical stage and pathological status of diffuse peripheral airway diseases like DPB.